QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

NCT06751277 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Recurrent or Metastatic Endometrial Cancer

Interventions

DRUG: QL1706 plus carboplatin plus paclitaxel for six to eight cycles at the investigator's discretion, followed by QL1706

Sponsor

xiang yang

Collaborators

[object Object]